1/6
08:55 am
supn
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $57.00 price target on the stock.
Low
Report
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $57.00 price target on the stock.
1/6
07:23 am
supn
Supernus initiated with an Overweight at Cantor Fitzgerald
Low
Report
Supernus initiated with an Overweight at Cantor Fitzgerald
1/6
06:20 am
supn
Supernus initiated with an Overweight at Cantor Fitzgerald
Low
Report
Supernus initiated with an Overweight at Cantor Fitzgerald